References:
1. Merriel A, Maharjan N, Clayton G, Toolan M, Lynch M, Barnard K, et
al. A cross-sectional study to evaluate antenatal care service provision
in 3 hospitals in Nepal. AJOG Glob Rep. 2021 Aug 1;1(3):100015. 2. Howes
RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, et al. G6PD
Deficiency Prevalence and Estimates of Affected Populations in Malaria
Endemic Countries: A Geostatistical Model-Based Map. PLOS Med. 2012 Nov
13;9(11):e1001339. 3. WHO Guidelines for malaria - 3 June 2022. 2022; 4.
Ashley EA, Recht J, White NJ. Primaquine: the risks and the benefits.
Malar J. 2014 Nov 3;13(1):418. 5. Yilma D, Groves ES, Brito-Sousa JD,
Monteiro WM, Chu C, Thriemer K, et al. Severe Hemolysis during
Primaquine Radical Cure of Plasmodium vivax Malaria: Two Systematic
Reviews and Individual Patient Data Descriptive Analyses. 2023 Oct 4
[cited 2024 Aug 8]; Available from:
https://www.ajtmh.org/view/journals/tpmd/109/4/article-p761.xml6. Watson
J, Taylor WR, Menard D, Kheng S, White NJ. Modelling primaquine-induced
haemolysis in G6PD deficiency. eLife. 6:e23061. 7. Brito MAM, Peixoto
HM, Almeida ACG de, Oliveira MRF de, Romero GAS, Moura-Neto JP, et al.
Validation of the rapid test Carestart(tm) G6PD among malaria
vivax-infected subjects in the Brazilian Amazon. Rev Soc Bras Med Trop.
2016 Aug;49:446–55. 8. Brito-Sousa JD, Santos TC, Avalos S, Fontecha G,
Melo GC, Val F, et al. Clinical Spectrum of Primaquine-induced Hemolysis
in Glucose-6-Phosphate Dehydrogenase Deficiency: A 9-Year
Hospitalization-based Study From the Brazilian Amazon. Clin Infect Dis
Off Publ Infect Dis Soc Am. 2019 Sep 27;69(8):1440–2. 9. Satyagraha AW,
Sadhewa A, Elvira R, Elyazar I, Feriandika D, Antonjaya U, et al.
Assessment of Point-of-Care Diagnostics for G6PD Deficiency in Malaria
Endemic Rural Eastern Indonesia. PLoS Negl Trop Dis. 2016 Feb
19;10(2):e0004457. 10. Epidemiology and Disease, Control Division,
Department of Health Services (2019). National Malaria Treatment
Protocol 2019. 11. Commons RJ, Simpson JA, Thriemer K, Chu CS, Douglas
NM, Abreha T, et al. The haematological consequences of Plasmodium vivax
malaria after chloroquine treatment with and without primaquine: a
WorldWide Antimalarial Resistance Network systematic review and
individual patient data meta-analysis. BMC Med. 2019 Aug 1;17(1):151.
12. Kosasih A, James R, Chau NH, Karman MM, Panggalo LV, Wini L, et al.
Case Series of Primaquine-Induced Haemolytic Events in Controlled Trials
with G6PD Screening. Pathogens. 2023 Sep;12(9):1176. 13. Pal S, Bansil
P, Bancone G, Hrutkay S, Kahn M, Gornsawun G, et al. Evaluation of a
Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase
Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate
Dehydrogenase Deficiency Closer to the Patient. Am J Trop Med Hyg. 2019
Jan;100(1):213–21. 14. Ley B, Thriemer K, Jaswal J, Poirot E, Alam MS,
Phru CS, et al. Barriers to routine G6PD testing prior to treatment with
primaquine. Malar J. 2017 Aug 10;16(1):329.